Dobutamine

Страна: Нова Зеландія

мова: англійська

Джерело: Medsafe (Medicines Safety Authority)

Активний інгредієнт:

Dobutamine hydrochloride 14.01 mg/mL equivalent to dobutamine 12.5 mg/mL;  

Доступна з:

REX Medical Ltd

ІПН (Міжнародна Ім'я):

Dobutamine hydrochloride 14.01 mg/mL (equivalent to dobutamine 12.5 mg/mL)

Дозування:

250 mg/20mL

Фармацевтична форма:

Concentrate for infusion

Склад:

Active: Dobutamine hydrochloride 14.01 mg/mL equivalent to dobutamine 12.5 mg/mL   Excipient: Hydrochloric acid Sodium hydroxide Sodium metabisulfite Water for injection

Тип рецепту:

Prescription

Виробник:

Bioindustria Laboratorio Medicinali SpA

Терапевтичні свідчення:

Dobutamine is indicated when inotropic support is necessary for the treatment of patients with hypoperfusion states in whom cardiac output is insufficient to meet circulatory demands. Dobutamine is also indicated when inotropic support is required for the treatment of patients in whom abnormally increased ventricular filling pressures introduce the risk of pulmonary congestion and oedema. Conditions which may precipitate such situations include the following hypoperfusion states: Initially cardiac in origin A. Acute heart failure 1. Acute myocardial infarction 2. Cardiogenic shock 3. Following cardiac surgery 4. Medicine-induced depression of cardiac contractility such as that which occurs in excessive ?- adrenergic receptor blockade. B. Chronic heart failure 1. Acute decompensation of chronic congestive heart failure 2. Temporary inotropic support in advanced chronic congestive heart failure, as an adjunct to therapy with conventional oral inotropic agents, systemic vasodilators, and diuretics. Initially noncardiac in origin 1. Acute hypoperfusion states secondary to trauma, surgery, sepsis, or hypovolaemia when mean arterial pressure is above 70-mm Hg and pulmonary capillary wedge pressure is 18-mm Hg or greater, with inadequate response to volume repletion and increased ventricular filling pressure 2. Low cardiac output secondary to mechanical ventilation with positive end-expiratory pressure (PEEP). Dobutamine is indicated in all paediatric age groups (from neonates to 18 years of age) as inotropic support in low cardiac output hypoperfusion states resulting from decompensated heart failure, following cardiac surgery, cardiomyopathies and in cardiogenic or septic shock.

Огляд продуктів:

Package - Contents - Shelf Life: Vial, glass, Type 1, with bromobutyl rubber stopper and aluminium cap - 20 mL - 24 months from date of manufacture stored at or below 25°C protect from light 24 hours opened stored at or below 25°C

Дата Авторизація:

2013-12-16